Levaggi Rosella, Pertile Paolo, Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition, APPLIED HEALTH ECONOMICS AND HEALTH POLICY, pp. 1-13, in…
Gamba Simona, Magazzini Laura, Pertile Paolo (2019) R&D and market size: who benefits from orphan drug regulation? Working Paper Series, Department of Economics, University of…
Biscardo C.A., Bucciol A.; Pertile P., Job Sick Leave: Detecting Opportunistic Behavior «Health Economics» , vol. 28 , n. 3 , 2019 , pp. 373-386…
Pertile P. (2018). Pertile P. , Gamba S., Foster M. (2018). Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence, Discussion Papers 18/04, Department of Economics,…
Pertile P., Chick S., Forster M. (2017). A Bayesian Decision-Theoretic Model of Sequential Experimentation with Delayed Response. Journal of the Royal Statistical Society Series B, …
Bucciol A., Cavalli L., Fedotenkov I., Pertile P., Polin V., Sartor N., Sommacal A. (2017). A Large Scale OLG Model for the Analysis of the…
Bucciol A., Cavalli L, Pertile P., Polin V., Sommacal A. (2016). Redistribution at the Local Level: The Case of Public Childcare in Italy. International Review…
Pertile P. (2017) Pertile P., Levaggi R., Moretto M. (2017). The Dynamics of Pharmaceutical Regulation and R&D Investments. Journal of Public Economic Theory, 19: 121-141.…
Pertile P., Jobjornsson S., Forster M., Burman C. F. (2016) Late-Stage Pharmaceutical R&D and Pricing Policies under Two-Stage Regulation. Journal of Health Economics, vol 50,…
Pertile P., Levaggi R. (2016). Pricing policies when patients are heterogeneous: a welfare analysis. (ISSN: 2036-2919, WP 17/2016). University of Verona DSE Working Paper series.…
